Our research uniquely highlights hepsin's role in counteracting APAP-induced liver damage, introducing an innovative combination therapy with NAC that enhances overall therapeutic effectiveness, marking a significant advancement in therapeutic approaches
"Triple-Hormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial." New England Journal of Medicine
Solubility and Storage Solubility and stability can change with salt form, peptide concentration, buffer, pH, temperature, light, oxygen, container material, and storage time
However, this review also noted that the quality of the studies was not very high, so more studies are needed before its possible to make any firm recommendations